繁体中文
设为首页
加入收藏
当前位置:药品说明书与价格首页 >> 综合药讯 >> 全球首个促睫毛生长剂-LATISSE0.03%眼用溶液

全球首个促睫毛生长剂-LATISSE0.03%眼用溶液

2009-08-14 11:22:42  作者:新特药房  来源:中国新药网  浏览次数:256  文字大小:【】【】【
简介:美国食品药品管理局(FDA)顾问委员会建议批准Allergan公司促进睫毛长、更浓密的药Latisse。 Latisse是青光眼治疗药物Lumigan的“孪生姐妹”,Lumigan滴眼液2001年获得FDA批准。在试验中,137例受试者给予Lati ...

 

Latisse Solution是美国食品药品管理局(FDA)顾问委员会首个唯一批准的促进睫毛更长、更浓密的药物。每套包括一瓶3ML溶液和60支专用刷。

在开始的研发试验中,137例受试者给予Latisse治疗,141例受试者应用安慰剂溶液4-16周。结果显示,Latisse组受试者在试验结束后睫毛更长、更浓密、更黑,同时他们表示比安慰剂组对自己的睫毛更满意。

FDA顾问委员会建议,对Latisse的研究应在特定人群,如青少年和由于化疗而睫毛脱落的患者中进行。Latisse最终在2009年成为同类型睫毛生长类药物中唯一被FDA批准的处方药。

Latisse 睫毛增长液 3ml 内含60个涂刷

LATISSE™ (bimatoprost ophthalmic solution) 0.03%, approved by the U.S. Food and Drug Administration (FDA) in 2008, is a novel treatment for hypotrichosis of the eyelashes. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes. LATISSE™ is the first and only FDA-approved, science-based treatment to enhance eyelash prominence as measured by increases in length, thickness and darkness of eyelashes.

Available only through a doctor, LATISSE™ is a once-daily prescription treatment applied to the base of the upper eyelashes with a sterile, single-use-per-eye disposable applicator. LATISSE™ users can expect to experience longer, fuller and darker eyelashes in as little as eight weeks, with full results in 16 weeks.   To maintain effect, continued treatment with LATISSE™ is required. If use of LATISSE™ is discontinued, eyelashes will gradually return to where they were prior to treatment over a period of weeks to months (average eyelash hair cycle). Ask your doctor if LATISSE™ is right for you.
Important Safety Information

LATISSE™ solution is intended for use on the skin of the upper eyelid margins at the base of the eyelashes. DO NOT APPLY to the lower eyelid. If you are using LUMIGAN® or other products in the same class for elevated intraocular pressure (IOP), or if you have a history of abnormal IOP, you should only use LATISSE™ under the close supervision of your doctor.

LATISSE™ use may cause darkening of the eyelid skin which may be reversible. Although not reported in clinical studies, LATISSE™ use may also cause increased brown pigmentation of the colored part of the eye which is likely to be permanent.

It is possible for hair growth to occur in other areas of your skin that LATISSE™ frequently touches. Any excess solution outside the upper eyelid margin should be blotted with a tissue or other absorbent material to reduce the chance of this from happening. It is also possible for a difference in eyelash length, thickness, fullness, pigmentation, number of eyelash hairs, and/or direction of eyelash growth to occur between eyes. These differences, should they occur, will usually go away if you stop using LATISSE™.

The most common side effects after using LATISSE™ solution are an itching sensation in the eyes and/or eye redness. This was reported in approximately 4% of patients. LATISSE™ solution may cause other less common side effects which typically occur on the skin close to where LATISSE™ is applied, or in the eyes. These include skin darkening, eye irritation, dryness of the eyes, and redness of the eyelids.

If you develop a new ocular condition (e.g., trauma or infection), experience a sudden decrease in visual acuity, have ocular surgery, or develop any ocular reactions, particularly conjunctivitis and eyelid reactions, you should immediately seek your doctor’s advice concerning the continued use of LATISSE™ solution.

【每晚使用方法】:

洁面及护肤
1.请于晚上睡觉前,取下隐形眼镜,清洁面部,并用完面部护理产品后,使用Latisse拉提丝睫毛增长液。

2.准备

取出洁净的小毛刷,在接近毛刷头部,挤一滴药液即可。

3.涂抹右眼睑

立即在右眼上眼皮靠近睫毛根部处涂抹Latisse拉提丝睫毛增长液。就像使用眼线液一样,感到湿润,但是没有液体流下即为正确用量。

4.如有过剩

如不小心涂到眼脸外侧,用纸巾抹去即可。

5.涂抹左眼睑

在涂抹完右眼睑后,请将小毛刷扔掉。取出新的小毛刷,重复同样的步骤,在左眼睑处涂上Latisse拉提丝睫毛增长液。

【使用疗程】:
又长又黑又浓密的睫毛可不是在一夜之间发生的。这就是为什么坚持而且正确的使用Latisse拉提丝睫毛增长液是非常重要。睫毛增长的效果是逐渐的,是从内到外的,是明显的。一旦你开始使用,你就可以看到在短短的4周的结果,但你必须继续坚持每天晚上使用。

责任编辑:admin


相关文章
 

最新文章

更多

· 无水酒精注射液(DEHYDR...
· DEHYDRATED ALCOHOL(无...
· 除铁能注射剂DESFERAL(D...
· ALBUMINAR IV SOLUTION(...
· Dantrium Intravenous I...
· Bunavail(盐酸丁丙诺啡...
· Dyloject(diclofenac so...
· THAM SOLUTION(trometha...
· THAM Injection SET(Tr...
· 首个基因新药Glybera注射...

推荐文章

更多

· 无水酒精注射液(DEHYDR...
· DEHYDRATED ALCOHOL(无...
· 除铁能注射剂DESFERAL(D...
· ALBUMINAR IV SOLUTION(...
· Dantrium Intravenous I...
· Bunavail(盐酸丁丙诺啡...
· Dyloject(diclofenac so...
· THAM SOLUTION(trometha...
· THAM Injection SET(Tr...
· 首个基因新药Glybera注射...

热点文章

更多

· 除铁能注射剂DESFERAL(D...
· DEHYDRATED ALCOHOL(无...
· 无水酒精注射液(DEHYDR...